Home Media/Press releases/Completion of second financing round>
Latest News
See all news


Press release

Completion of second financing round

Lyon, France, May 13, 2014 – Orega Biotech, the biotech company dedicated to the development of novel cancer therapies, announces today the completion of its second round of financing through a private investment from the historical investors, SHAM, a Lyon-based insurance company specialized in medical malpractice liability insurance, Rhône-Alpes Création, a private Venture Capital Company which invests in innovative start-ups based in the Rhone-Alpes region and OCTALFA, a French holding company managed by Gilles Alberici.

Download the press release.

See all our press releases

See all events